Citation Impact
Citing Papers
Marijuana and the Cannabinoids
2007
Prior Exposure to THC Increases the Addictive Effects of Nicotine in Rats
2013
Glutamate receptor ion channels
2005 Standout
Glutamate Receptor Ion Channels: Structure, Regulation, and Function
2010 Standout
Chronic Mild Stress (CMS) Revisited: Consistency and Behavioural-Neurobiological Concordance in the Effects of CMS
2005 Standout
Cannabinoid physiology and pharmacology: 30 years of progress
2004
Treating schizophrenia symptoms with an α7 nicotinic agonist, from mice to men
2007
Endocannabinoid system and alcohol addiction: Pharmacological studies
2005
A role for polyamines in retinal ganglion cell excitotoxic death
2007
Cannabinoids, opioids and eating behavior: The molecular face of hedonism?
2005
Control of the reinforcing effects of nicotine by associated environmental stimuli in animals and humans
2005
Adverse Health Effects of Marijuana Use
2014 Standout
Elicited hippocampal theta rhythm: a screen for anxiolytic and procognitive drugs through changes in hippocampal function?
2007
Brain lesions and delayed water maze learning deficits after intracerebroventricular spermine
1998
Natural products: An evolving role in future drug discovery
2011 Standout
Pharmacotherapy for Nicotine Dependence
2005
Rats on the grog: Novel pharmacotherapies for alcohol craving
2004
Comparison of the efficacy, safety, and onset of action of mizolastine, cetirizine, and placebo in the management of seasonal allergic rhinoconjunctivitis
1999
Nicotine Self-Administration Induces CB1-Dependent LTP in the Bed Nucleus of the Stria Terminalis
2014
Δ9‐tetrahydrocannabinol decreases somatic and motivational manifestations of nicotine withdrawal in mice
2004
Effects of the cannabinoid CB1 receptor antagonist rimonabant in models of emotional reactivity in rodents
2005
The endocannabinoid system in the basal ganglia and in the mesolimbic reward system: implications for neurological and psychiatric disorders
2003
REVIEW ON CPP: Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade
2007 Standout
Cellular signaling and factors involved in Müller cell gliosis: Neuroprotective and detrimental effects
2009 Standout
Taming THC: potential cannabis synergy and phytocannabinoid‐terpenoid entourage effects
2011 Standout
Efficacy and Safety of Mizolastine in Seasonal Allergic Rhinitis
1996
Subunit- and site-specific pharmacology of the NMDA receptor channel
1999
Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003
2004 Standout
Cannabinoid CB1 receptors are involved in motivational effects of nicotine in rats
2005
Involvement of the endocannabinoid system in drug addiction
2006
Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases
2015 Standout
Mismatches between neurotransmitter and receptor localizations in brain: observations and implications
1987
Conantokin G Is an NR2B-Selective Competitive Antagonist ofN-Methyl-d-aspartate Receptors
2000
A practical guide to diagnostic transcranial magnetic stimulation: Report of an IFCN committee
2012 Standout
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
2006 Standout
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Role of the cannabinoid system in the effects induced by nicotine on anxiety-like behaviour in mice
2006
Cannabinoid CB1 receptors control conditioned drug seeking
2005
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
Identification of a mammalian vesicular polyamine transporter
2014
Nicotine-Associated Cues Maintain Nicotine-Seeking Behavior in Rats Several Weeks after Nicotine Withdrawal: Reversal by the Cannabinoid (CB1) Receptor Antagonist, Rimonabant (SR141716)
2004
Novelty and Anxiolytic Drugs Dissociate Two Components of Hippocampal Theta in Behaving Rats
2013 StandoutNobel
A within-trial cost-effectiveness analysis of primary care referral to a commercial provider for weight loss treatment, relative to standard care—an international randomised controlled trial
2012 Standout
Direct Immunohistochemical Evidence of the Existence of 5‐HT1A Autoreceptors on Serotoninergic Neurons in the Midbrain Raphe Nuclei
1990
Endogenous cannabinoids are not involved in cocaine reinforcement and development of cocaine-induced behavioural sensitization
2004
Leptin Resistance and Obesity
2006
Lack of CB1 Cannabinoid Receptor Impairs Cocaine Self-Administration
2005
Nicotine as a typical drug of abuse in experimental animals and humans
2005
Modulation and Block of Ion Channels: A New Biology of Polyamines
1997
The preterm parturition syndrome
2006 Standout
Obesity and Cardiovascular Disease
2009 Standout
Induction of premature labor and delivery by allergic reaction and prevention by histamine H1 receptor antagonist
2004
Inhibition of mediator and cytokine release from dispersed nasal polyp cells by mizolastine
2002
The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9‐tetrahydrocannabinol, cannabidiol and Δ9‐tetrahydrocannabivarin
2007 Standout
Age-related changes in polyamines in memory-associated brain structures in rats
2008
The use of spirocyclic scaffolds in drug discovery
2014 Standout
Nicotine induces conditioned place preferences over a large range of doses in rats
2004
Interplay between Cortical Spreading Depolarization and Seizures
2017 Standout
Polyamine Regulation of N-Methyl-D-Aspartate Receptor Channels
1995
Global strategy for asthma management and prevention: GINA executive summary
2007 Standout
Modulation of channel function by polyamines
1996
Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects
2008 Standout
Major Depressive Disorder
2008 Standout
Integrated physiology and pathophysiology of CB1-mediated effects of the endocannabinoid system
2007
The NR2B-specific Interactions of Polyamines and Protons with theN-Methyl-d-aspartate Receptor
1997
A Comprehensive Profile of Brain Enzymes that Hydrolyze the Endocannabinoid 2-Arachidonoylglycerol
2007 Standout
Imaginary Relish and Exquisite Torture: The Elaborated Intrusion Theory of Desire.
2005 Standout
Neurocircuitry of stress: central control of the hypothalamo–pituitary–adrenocortical axis
1997 Standout
GABA and mood disorders: a brief review and hypothesis
1995
GABAergic dysfunction in mood disorders
2003
Cannabinoid CB1 Receptor Antagonists as Promising New Medications for Drug Dependence
2005
Endocannabinoid-Mediated Control of Synaptic Transmission
2009
Histamine potentiates N-methyl-d-aspartate responses in acutely isolated hippocampal neurons
1993
Endocannabinoid system and opioid addiction: Behavioural aspects
2005
Rimonabant, a CB1 antagonist, blocks nicotine-conditioned place preferences
2004
Is there a role for the endocannabinoid system in the etiology and treatment of melancholic depression?
2005
Differential involvement of the endocannabinoid system in short- and long-term expression of incentive learning supported by nicotine in rats
2006
Endocannabinoid system and stress and anxiety responses
2005
Neurobiology of addiction: a neurocircuitry analysis
2016 Standout
Abnormal response of motor cortex to photic stimulation in idiopathic generalized epilepsy
2008
Second-Generation Antihistamines
1999
Uso terapêutico dos canabinoides em psiquiatria
2010
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
Allosteric Modulators of the α7 Nicotinic Acetylcholine Receptor
2008
Interactions of polyamines with ion channels
1997
Nicotine replacement therapy for smoking cessation
2012 Standout
Applications of the Morris water maze in the study of learning and memory
2001 Standout
The Endocannabinoid System: Drug Targets, Lead Compounds, and Potential Therapeutic Applications
2005
Novel Pharmacological Approaches for Treating Tobacco Dependence and Withdrawal
2008
Mizolastine provides effective symptom relief in patients suffering from perennial allergic rhinitis: a double-blind, placebo-controlled study versus loratadine
2002
Advances in the Chemistry of Tetrahydroquinolines
2011 Standout
Spermidine in health and disease
2018 StandoutScience
Effect of the cannabinoid CB1 receptor antagonist SR-141716A on ethanol self-administration and ethanol-seeking behaviour in rats
2005
Cannabinoids in health and disease
2007
The Glutamate Receptor Ion Channels
1999 Standout
Cannabinoid CB1 receptor knockout mice exhibit markedly reduced voluntary alcohol consumption and lack alcohol‐induced dopamine release in the nucleus accumbens
2003
Rab3B protein is required for long-term depression of hippocampal inhibitory synapses and for normal reversal learning
2011 StandoutNobel
Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study
1991 Standout
CANNABINOID RECEPTORS AS THERAPEUTIC TARGETS
2005
Discovery and Development of α7 Nicotinic Acetylcholine Receptor Modulators
2011
Cannabinoid antagonist SR-141716 inhibits endotoxic hypotension by a cardiac mechanism not involving CB1 or CB2 receptors
2004
Arginine metabolism: nitric oxide and beyond
1998 Standout
Physiology of Microglia
2011 Standout
Hallucinogens
2004 Standout
The natural polyamine spermine functions directly as a free radical scavenger
1998 Standout
Works of C. Voltz being referenced
Difluoromethyl ornithine protects against the neurotoxic effects of intrastriatally administered N-methyl-D-aspartate in vivo
1991
The effects ofN-methyl-d-aspartate and kainate lesions of the rat striatum on striatal ornithine decar☐ylase activity and polyamine levels
1991
Release of spermidine from the rat cortex following permanent middle cerebral artery occlusion
1995
Selective Release of Spermine and Spermidine from the Rat Striatum by N‐Methyl‐d ‐Aspartate Receptor Activation In Vivo
1992
SR141716, a central cannabinoid (CB1) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats
2002
SSR180711, a Novel Selective α7 Nicotinic Receptor Partial Agonist: (II) Efficacy in Experimental Models Predictive of Activity Against Cognitive Symptoms of Schizophrenia
2006
The plasma concentration of GABA shows no evidence of a circadian rhythm and is stable over weeks in normal males
1994
Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent.
1995
Cerebrospinal fluid amino acid and monoamine metabolite levels ofPapio papio: correlation witphotosensitivity
1986